These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6531040)

  • 1. Pharmacokinetics and pharmacodynamics of psoralens after oral administration: considerations and conclusions.
    Brickl R; Schmid J; Koss FW
    Natl Cancer Inst Monogr; 1984 Dec; 66():63-7. PubMed ID: 6531040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Difference in topical and systemic reactivity of psoralens: determinations of epidermal and serum levels.
    Kornhauser A; Wamer WG; Giles AL
    Natl Cancer Inst Monogr; 1984 Dec; 66():97-101. PubMed ID: 6531046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacology of oral psoralen drugs.
    Brickl R; Schmid J; Koss FW
    Photodermatol; 1984 Aug; 1(4):174-86. PubMed ID: 6397736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and therapeutic effectiveness of 8-methoxypsoralen, 4,5',8-trimethylpsoralen, and psoralen in vitiligo.
    Pathak MA; Mosher DB; Fitzpatrick TB
    Natl Cancer Inst Monogr; 1984 Dec; 66():165-73. PubMed ID: 6531024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous phototoxicity due to psoralens.
    Gange RW; Parrish JA
    Natl Cancer Inst Monogr; 1984 Dec; 66():117-26. PubMed ID: 6531018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and therapeutic effectiveness of selected psoralens in psoriasis.
    Wolff K; Hönigsmann H
    Natl Cancer Inst Monogr; 1984 Dec; 66():159-64. PubMed ID: 6531023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative tests for psoralens in the blood: methods and uses in monitoring psoralen and longwave radiation therapy.
    Carter DM; Goldstein DP
    Natl Cancer Inst Monogr; 1984 Dec; 66():69-72. PubMed ID: 6531041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of sister chromatid exchanges and gene mutations in Chinese hamster ovary cells by psoralens.
    Loveday KS; Donahue BA
    Natl Cancer Inst Monogr; 1984 Dec; 66():149-55. PubMed ID: 6531021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between 8-methoxypsoralen bath-water concentration and photosensitivity in bath-PUVA treatment.
    Tanew A; Kipfelsperger T; Seeber A; Radakovic-Fijan S; Hönigsmann H
    J Am Acad Dermatol; 2001 Apr; 44(4):638-42. PubMed ID: 11260539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psoralens: a search for more effective derivatives for photochemotherapeutic regimens.
    Willis I; Menter JM
    Natl Cancer Inst Monogr; 1984 Dec; 66():143-7. PubMed ID: 6531020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of time-dependent response to psoralen plus UVA (PUVA) treatment with topical 8-methoxypsoralen (8-MOP) gel in palmoplantar dermatoses.
    Engin B; Oguz O
    Int J Dermatol; 2005 Apr; 44(4):337-9. PubMed ID: 15811091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phototoxicity of new psoralen-containing gels and creams versus bath PUVA.
    Nimkulrat P; Leenutaphong V; Sudtim S
    J Med Assoc Thai; 2005 Oct; 88(10):1406-11. PubMed ID: 16519387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-response relations in phototoxicity due to 8-methoxypsoralen and UV-A in man.
    Ljunggren B; Bjellerup M; Carter DM
    J Invest Dermatol; 1981 Feb; 76(2):73-5. PubMed ID: 7462679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioavailability study of two different 8-methoxypsoralen (8-MOP) preparations in patients receiving PUVA therapy.
    Nørgaard M; Hueg B; Staberg B
    Photodermatol; 1985 Aug; 2(4):252-6. PubMed ID: 3903679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinogenic effects of monofunctional and bifunctional furocoumarins.
    Mullen MP; Pathak MA; West JD; Harrist TJ; Dall'Acqua F
    Natl Cancer Inst Monogr; 1984 Dec; 66():205-10. PubMed ID: 6531030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biopharmaceutics, pharmacokinetics and pharmacology of psoralens.
    Stolk LM; Siddiqui AH
    Gen Pharmacol; 1988; 19(5):649-53. PubMed ID: 3063592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro characterization of the reaction of four psoralen derivatives with DNA.
    Isaacs ST; Wiesehahn G; Hallick LM
    Natl Cancer Inst Monogr; 1984 Dec; 66():21-30. PubMed ID: 6531031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of UV-B erythema of psoralen, trimethylpsoralen, and 8 methoxypsoralen.
    Coupez L; Agache PG; Petigny M
    Acta Derm Venereol; 1980; 60(5):456-9. PubMed ID: 6162327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of 8-methoxypsoralen vs. 5-methoxypsoralen plus ultraviolet A therapy in patients with mycosis fungoides.
    Wackernagel A; Hofer A; Legat F; Kerl H; Wolf P
    Br J Dermatol; 2006 Mar; 154(3):519-23. PubMed ID: 16445785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time course of 8-methoxypsoralen concentrations in skin and plasma after topical (bath and cream) and oral administration of 8-methoxypsoralen.
    Tegeder I; Bräutigam L; Podda M; Meier S; Kaufmann R; Geisslinger G; Grundmann-Kollmann M
    Clin Pharmacol Ther; 2002 Mar; 71(3):153-61. PubMed ID: 11907489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.